Summer Special! Get NewsNow Essentials at just £1.99 a month (50% OFF!). Faster, slicker, customisable & ad free!Summer Special! Get NewsNow Essentials at just £1.99 a month (50% OFF!). Subscribe and saveSummer Special! Upgrade here at £1.99/m (50% OFF!)

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
AI
Business
Football
Sport
Entertainment
Tech
Science

Regeneron
Health
Diabetes
Cancer
Disability
Heart Disease
Diet and Fitness
Obesity
Mental Health
Reproductive Health
Assisted Dying
Topics

Advertisement

Regeneron

Share

Top Latest Popular

🧊 FINALLY, SOMETHING COOL! £1.99 a month for NewsNow Essentials. Upgrade here

🧊 FINALLY, SOMETHING COOL! NewsNow Essentials at just £1.99 a month. Faster, slicker & ad free. Upgrade here

Yesterday

Does First-in-Class FOP Drug Approval Transform the Bull Case For Regeneron Pharmaceuticals (REGN)? Simply Wall St 12:41 Sun, 23 Aug

Friday

Biocon Launches Aflibercept Biosimilar in the United States JD Supra 18:09 Fri, 21 Aug

Action Alleging Drug Company Kickback Scheme Is Revived Metropolitan News-Enterprise, Los Angeles 15:14 Fri, 21 Aug

Advertisement

Advertisement

Regeneron podcast turns science learnings into immersive experience FiercePharma 07:56 Fri, 21 Aug

Thursday

Regeneron Secures FDA Approval for Rare Genetic Disorder Drug Zacks 16:44 Thu, 20 Aug

Regn Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Regeneron Pharmaceuticals Securities Lawsuit - Contact Levi & Korsinsky Business Wire (Press Release) 15:19 Thu, 20 Aug

STAT Plus: Pharmalittle: We’re reading about a Regeneron rare disease drug, an Ultragenyx gene therapy, and more STAT 14:12 Thu, 20 Aug

Regeneron’s Pasatru wins FDA approval in ultra-rare ‘stone man disease’ Pharmaceutical Technology 12:11 Thu, 20 Aug

Wednesday

Ninth Circuit Revives Regeneron Kickback Whistleblower Lawsuit Bloomberg Law 23:45 Wed, 19 Aug

Pasatru’s FDA Approval Puts Regeneron’s Rare-Disease Playbook To The Test Scrip Pharma Intelligence 23:15 Wed, 19 Aug

Meet Audrey Zheng, the 17-year-old Pennsylvania student who developed a pancreatic cancer test; it correctly identified 87% of patients and 87.5% without the disease The Times of India 21:47 Wed, 19 Aug

Regeneron’s Pasatru wins FDA nod in ultra-rare fop BioWorld 21:34 Wed, 19 Aug

Regeneron Announces Investor Conference Presentations Regeneron Pharmaceuticals (Press Release) 21:13 Wed, 19 Aug

FDA greenlights Regeneron drug for rare bone disease pharmaphorum 20:23 Wed, 19 Aug

Regeneron's Pasatru scores FDA approval in ultrarare bone lesions disorder FiercePharma 19:39 Wed, 19 Aug

Regeneron Wins FDA Approval For Pasatru To Reduce New Bone Lesions In fop RTT News 19:33 Wed, 19 Aug

Pasatru™ (garetosmab-grts) First and Only FDA-approved Treatment Demonstrating Reduction in New Heterotopic Ossification (HO) Lesions and Clinician-Assessed Flare-ups in a Placebo-controlled Trial in Adults with Fibrodysplasia Ossificans Progressiva (FOP) Regeneron Pharmaceuticals (Press Release) 18:59 Wed, 19 Aug

STAT Plus: Regeneron drug for disease that causes dangerous bone growth earns FDA approval STAT 18:06 Wed, 19 Aug

Advertisement

Regeneron’s Uveitis Setback Adds To String Of Recent Pipeline Challenges Scrip Pharma Intelligence 10:40 Wed, 19 Aug

Sam Chun Dang clears Eylea patent disputes as SCD411 exports grow Korea Biomedical Review 07:11 Wed, 19 Aug

In the last month

Spotlight On: Biosimilar Litigations - August 2026 JD Supra 22:50 Mon, 17 Aug

EyePoint's drug for age-related eye disease fails late-stage trial, shares tank 70% The Economic Times 16:45 Mon, 17 Aug

Meet Vedika Devarajan, the Washington high-school freshman who designed a banana-inspired neonatal incubator liner to tackle hospital-acquired infections The Times of India 16:19 Mon, 17 Aug

Meet Ananya Nagendra, the 18-year-old Texas student who built an ant-based digester for landfill food waste; tests found her prototype was about 83% efficient The Times of India 14:27 Mon, 17 Aug

Meet Connor Hill, the 17-year-old Pennsylvania student who wrote a computer program to classify noble polyhedra; he proved there are 146 isolated examples and won $250,000 The Times of India 13:30 Sun, 16 Aug

Minnesota teen Evan Morris built a low-cost system that detected seizure-like activity in worms and triggered ultrasound; recurrence fell 70.1% in his model The Times of India 08:47 Sat, 15 Aug

GLP-1 Demand Is Soaring. 2 Stocks That Could Benefit From This (Hint: Not Eli Lilly or Novo Nordisk) The Motley Fool 00:00 Sat, 15 Aug

Biocon Announces Launch of EYLEA® Interchangeable Biosimilar Yesafili™ While PGR Denied Institution JD Supra 18:53 Fri, 14 Aug

Biopharma saw a Q2 sales boom led by Lilly, Sanofi, Regeneron and Astellas FiercePharma 16:49 Wed, 12 Aug

STAT Plus: Skylar Bio kicks off new gene therapy trial for deafness STAT 13:03 Tue, 11 Aug

NTLA Q2 Earnings In Line, Top Line Misses on Lower Regeneron Revenues Zacks 16:58 Fri, 07 Aug

Investor alert: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - Regn PR Newswire (Press Release) 02:59 Fri, 07 Aug

Lawton Chiles High School student wins Humane Science Award from National Anti-Vivisection Society PR Newswire (Press Release) 12:01 Thu, 06 Aug

Surging Earnings Estimates Signal Upside for Regeneron (REGN) Stock Zacks 18:26 Wed, 05 Aug

Regn Stock Drop: If You Lost Money Investing in Regeneron Pharmaceuticals, Inc. Contact Robbins LLP for Information About Leading the Class Action Lawsuit Business Wire (Press Release) 15:13 Wed, 05 Aug

Regeneron (REGN) is a Top-Ranked Value Stock: Should You Buy? Zacks 15:44 Tue, 04 Aug

Biocon Announces U.S. Commercial Launch of Yesafili™, a Biosimilar to Regeneron’s Eylea® 2 mg Business Wire (Press Release) 12:07 Mon, 03 Aug

Regeneron (REGN) Stock Price Faces Margin Squeeze Despite 17% Revenue Growth Simply Wall St 08:20 Sat, 01 Aug

Regeneron Awards $150,000 to Winners of the 2026 Regeneron Prize for Creative Innovation Regeneron Pharmaceuticals (Press Release) 12:01 Fri, 31 Jul

Regeneron Q2 Earnings Beat, Sales Up on Dupixent & Eylea HD Strength Zacks 18:01 Thu, 30 Jul

Advertisement

Advertisement

Regeneron News

Latest news and updates on Regeneron Pharmaceuticals, an American biotechnology company that was founded in 1988. The company is listed on NASDAQ.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Health Health
Back to Lifestyle Health
- Diet and Fitness
- Mental Health
- Cancer Cancer
- Diabetes Diabetes
- Disability Disability
- Gastrointestinal Diseases
- Infectious Diseases
- Neurological Diseases
- Reproductive Health
- Sexual Health
- Allergies Allergies
- Alopecia Alopecia
- Antibiotic Resistance
- Assisted Dying
- Blood Disorders
- Heart Disease
- Obesity Obesity
- PTSD PTSD
- Rare Diseases
- SIDS SIDS